InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Bisker-Leib Vered, Chief Operating Officer. Director active across 1 company, notably Compass Therapeutics, Inc.. Cumulatively, 7 reports have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €87k. Activity tracked since 16 November 2021. The latest transaction was filed on 8 February 2024 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Bisker-Leib Vered
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
49,198 shares@ US$1.452.0% of flowCommon StockSEC:0001171843-24-000715:0
1,753,125 shares@ US$1.9392.7% of flowCommon StockSEC:0001171843-24-000179:0
64,415 shares@ US$1.502.7% of flowCommon StockSEC:0001171843-23-007223:0
400,000 shares0Common StockSEC:0001171843-23-000846:0
14,929 shares@ US$4.191.8% of flowCommon StockSEC:0001171843-22-007662:0
6,226 shares@ US$4.400.8% of flowCommon StockSEC:0001171843-22-007635:0
600,000 shares0Common StockSEC:0000899243-21-045309:0
7 of 7 declarations
About Bisker-Leib Vered
Bisker-Leib Vered is Chief Operating Officer and is linked to Compass Therapeutics, Inc., where she holds the role of CHIEF EXECUTIVE OFFICER. She has 7 filings in total, and across the 7 sampled filings between 2021-11-18 and 2024-02-09, sales total 87491 EUR and no purchases are shown; the most frequent transaction nature is Attribution.
